Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
VIDEO: Hooked on ID with Connie Steed, MSN, RN, CIC, FAPIC
SAN ANTONIO — We caught up with Connie Steed, MSN, RN, CIC, FAPIC, at the annual meeting of the Association for Professionals in Infection Control and Epidemiology to find out how she got “Hooked on ID.”
Q&A: A checkup with CDC Director Mandy K. Cohen, MD, MPH
We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves Merck’s pneumococcal vaccine for adults
The FDA has approved Merck’s 21-valent pneumococcal vaccine, which is specifically made for adults, the company announced.
Q&A: Are combination vaccines the future for respiratory infections?
Moderna announced positive phase 3 trial data for its combination COVID-19 and influenza vaccine this week, suggesting a combination shot for respiratory infections is on the way.
COVID-19 disrupted RSV seasons, leading to more hospitalizations
COVID-19 mitigation measures disrupted the circulation of respiratory syncytial virus, leading to atypical season in 2021 and 2022 that saw higher rates of hospitalization among young children, according to research published in Pediatrics.
Q&A: Will Moderna's mRNA RSV vaccine increase uptake next respiratory virus season?
In late May, the FDA announced approval of Moderna's mResvia, marking the third vaccine approved for respiratory syncytial virus and first time messenger RNA technology has been used for preventing a disease other than COVID-19.
Publicly insured children less likely to receive nirsevimab for RSV
Children in Massachusetts who were publicly insured or living in less affluent ZIP codes were less likely to receive nirsevimab, a monoclonal antibody for respiratory syncytial virus, according to research published in Pediatrics.
Amikacin safe, improves respiratory symptoms in M. avium complex lung disease
SAN DIEGO — Amikacin for 6 months improved respiratory symptoms in adults with newly diagnosed or recurrent Mycobacterium avium complex lung disease, according to a presentation at the American Thoracic Society International Conference.
Entry screening for measles at hospitals may reduce risk for exposure
SAN ANTONIO — A hospital in Seattle started a measles entry screening program for all visitors after an outbreak in the city, finding the measures were easy to put in place and deemed acceptable by patients, according to a study.
FDA approves Moderna’s mRNA vaccine for RSV
The FDA has approved Moderna's mResvia, a messenger RNA vaccine to protect adults 60 years or older from lower respiratory tract disease caused by respiratory syncytial virus.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read